ABSTRACT
BACKGROUND: Multiple synergistic combination approaches with cancer drugs are developed to overcome primary resistance to immunotherapy; however, the mechanistic rationale to combine chemoradiotherapy (CRT) with immune checkpoint inhibitors remains elusive. METHODS: This study described the immunological landscape of tumor microenvironment (TME) exposed to CRT. Tumor samples from patients with rectal cancer (n=43) treated with neoadjuvant CRT or radiotherapy were analyzed by nanostring and immunohistochemistry. Studies in mice were performed using three syngeneic tumors (TC1, CT26 and MC38). Tumor-bearing mice were treated either with platinum-based CRT, radiotherapy or chemotherapy. Anti-CTLA-4 and/or anti-Programmed Cell Death Receptor-1 (PD-1) therapy was used in combination with CRT. The therapy-exposed TME was screened by RNA sequencing and flow cytometry and tumor-infiltrating T lymphocyte functionality was evaluated by interferon (IFN)-γ ELIspot and intracellular cytokine staining. RESULTS: Front-to-front comparison analysis revealed the synergistic effect of CRT to establish a highly inflamed and Th1-polarized immune signature in the TME of patients and mice. In both settings, CRT-exposed TMEs were highly enriched in newly-infiltrated tumor-specific CD8+ T cells as well as tissue resident memory CD103+CD8+ T cells. In mice, CD8 T cells were involved in the antitumor response mediated by CRT and were primed by CRT-activated CD103+ dendritic cells. In the three tumor models, we showed that concurrent combination of CRT with a dual CTLA-4 and PD-1 blockade was required to achieve an optimal antitumor effect and to establish a broad and long-lasting protective antitumor T cell immunity. CONCLUSIONS: Our results highlight the ability of CRT to stimulate strong antitumor T-cell-mediated immunity and tissue resident memory T activation in TME, to foster immune checkpoint inhibitors action. These findings have implications in clinic for the design clinical trials combining chemoradiation with immunotherapy.
Subject(s)
Chemoradiotherapy/methods , Immune Checkpoint Inhibitors/therapeutic use , Immunity/immunology , Immunotherapy/methods , Th1 Cells/radiation effects , Animals , Disease Models, Animal , Female , Humans , Immune Checkpoint Inhibitors/pharmacology , Mice , Tumor MicroenvironmentABSTRACT
Extensive evidence has documented that the balance between cytokines from T helper type 1 (Th1) and type 2 (Th2) cells is disrupted in the tumorigenic microenvironment compared with immunocompetent individuals. Ionizing radiation (IR) has been reported to markedly modulate the Th1/Th2 polarization in a concentrationdependent manner. In the present review article, the immune modulation of Th1/Th2 and the IRinduced crosstalk of the Th1/Th2 shift with immunocytes and tumor cells are summarized. The involvement of the Th1/Th2 shift in postradiotherapy complications is highlighted. Specifically, highdose IR has been shown to promote the Th2 shift, leading to an immunosuppressive cytokine network, while the impact of lowdose IR remains controversial. The IRinduced modulation of the Th1/Th2 shift is mediated by tumor cells and multiple immunocytes, including dendritic cells, tumorassociated macrophages, cytotoxic T lymphocytes and natural killer cells. However, the excessive production of proinflammatory factors, such as IFNγ and IL2, by Th1 cells, aggravates the clinical sideeffects of radiotherapy, including radiationinduced lung and intestinal injury, radiation encephalopathy, as well as other complications. Therefore, further research into the underlying mechanism is required to confirm the potential applicability of the Th1/Th2 shift combined with IR in the treatment of malignant tumors.
Subject(s)
Neoplasms/radiotherapy , Th1 Cells/immunology , Th2 Cells/immunology , Cell Polarity/drug effects , Cytokines/metabolism , Dose-Response Relationship, Radiation , Gene Expression Regulation, Neoplastic/radiation effects , Humans , Neoplasms/immunology , Th1 Cells/radiation effects , Th2 Cells/radiation effectsABSTRACT
In mycosis fungoides (MF), cutaneous granuloma formation is unusual. Furthermore, MF showing interstitial granuloma, a rare type, after combination therapy with interferon-gamma (IFN-γ) and narrowband UVB (nbUVB) has not been previously reported. A 77-year-old man was referred to our hospital with a 2-month history of erythroderma. Biopsied specimens revealed infiltration of atypical lymphocytes and eosinophils. A diagnosis of an erythrodermic variant of MF was made. He was treated with combination therapy of IFN-γ and nbUVB. After the therapy, papules newly appeared and a histopathological specimen revealed interstitial granuloma. There were several CXCR3-positive cells around the granuloma. We speculated that the combination therapy made T-helper 1 cells migrate to the cutaneous lesion and resulted in the granuloma formation. Furthermore, judging from the disappearance of elastic fibers around the interstitial granuloma, we considered that IFN-γ may induce the infiltration of histiocytes interstitially after damage of elastic fibers caused by nbUVB therapy, and both IFN-γ and nbUVB may thus play an important role in the histogenesis. Not only histopathology but also immunological observations are needed to elucidate the mechanisms underlying the development of different types of granuloma in MF.
Subject(s)
Granuloma/immunology , Granuloma/pathology , Interferon-gamma/adverse effects , Mycosis Fungoides/pathology , Ultraviolet Therapy/adverse effects , Adult , Aged , Antiviral Agents/adverse effects , Antiviral Agents/therapeutic use , Biopsy/methods , Combined Modality Therapy/methods , Dermatitis, Exfoliative/diagnosis , Dermatitis, Exfoliative/pathology , Female , Granuloma/chemically induced , Granuloma/diagnosis , Histiocytes/drug effects , Histiocytes/pathology , Humans , Immunohistochemistry/methods , Interferon-gamma/therapeutic use , Male , Middle Aged , Mycosis Fungoides/diagnosis , Mycosis Fungoides/drug therapy , Mycosis Fungoides/radiotherapy , Receptors, CXCR3/metabolism , Skin Neoplasms/pathology , Th1 Cells/drug effects , Th1 Cells/pathology , Th1 Cells/radiation effects , Ultraviolet Therapy/methodsSubject(s)
Balneology/methods , Phototherapy/methods , Psoriasis/therapy , Skin/cytology , Th17 Cells/radiation effects , Ultraviolet Rays , Ultraviolet Therapy/methods , Adult , Female , Hot Springs , Humans , Iceland , Inflammation , Interleukins/metabolism , Leukocytes, Mononuclear/metabolism , Male , Middle Aged , Psoriasis/blood , Seawater , Severity of Illness Index , Skin/radiation effects , T-Lymphocytes, Cytotoxic/cytology , T-Lymphocytes, Cytotoxic/radiation effects , Th1 Cells/cytology , Th1 Cells/radiation effects , Th17 Cells/cytology , Interleukin-22ABSTRACT
Immune cells are known as the most sensitive tissue for ionizing radiation. Numerous reports relating with the effect of low-dose ionizing radiation (LDIR) on immune activities showed that LDIR can induce immune-potentiation via modulating the activity of B-, T-, and NK cells, or macrophages, whereas high-dose radiation induces genome-wide apoptotic/necrotic tissue injury and immune suppression. Generally, CD4+ T-cells play pivotal roles in immune systems via cytokines and cell-surface molecules to activate other types of immune cells to eliminate the pathogen. In spite of the significance of CD4+ T-cells in the immune system, mechanism of how LDIR regulates CD4+ T-cell gene expression is poorly investigated. Thus, RNA-Seq and Gene-Set Enrichment Analysis (GSEA) analysis were done with low-dose irradiated (γ-radiation, 50 mGy, 204 mGy/h)/anti-CD3/CD28-stimulated CD4+ T-cells to explore the LDIR-specific regulation of CD4+ T-cell gene expression. The results indicated that the genes related to mRNA translation processes, mitochondrial function, cell cycle regulation, and cytokine induction were upregulated in irradiated cells. Moreover, this study showed that the expression of T-helper cell Type 1 (TH1) or type 2 (TH2) cytokine genes, such as those for interferon (IFN)-γ, interleukin (IL)-4, and IL-5 were increased by at least 1.4-fold in acute (204 mGy/h) or chronic (10 mGy/h) low-dose (10 or 50 mGy) irradiated/anti-CD3/CD28 stimulated CD4+ T-cells, whereas the T-regulatory (Treg) cell cytokine gene, transforming growth factor (TGF)-ß was decreased. Overall, these findings demonstrated that LDIR could cause an upregulation of selected immune product genes and, in turn, might modulate the activity of CD4+ T-cells undergoing activation via an impact on cytokine gene regulation.
Subject(s)
Mitochondria/physiology , Radiation, Ionizing , T-Lymphocytes, Regulatory/physiology , Th1 Cells/physiology , Th2 Cells/physiology , Animals , CD4 Antigens/metabolism , Cell Cycle/genetics , Cells, Cultured , Cytokines/genetics , Gene Expression Profiling , Gene Expression Regulation/radiation effects , Lymphocyte Activation/genetics , Male , Mice , Mice, Inbred C57BL , Protein Biosynthesis/genetics , Sequence Analysis, RNA , T-Lymphocytes, Regulatory/radiation effects , Th1 Cells/radiation effects , Th2 Cells/drug effectsABSTRACT
Exposure to ionizing radiation (IR) often reduce the helper T (Th) 1 like function, resulting in a Th1/Th2 imbalance, which could affect the efficacy of cancer radiotherapy. As the most potent antigen presenting cells, dendritic cells (DC) can be divided into several subsets with specialized function. However, there is no literature covering the changes of DC subsets and their roles in immune regulation in response to IR. In the present study, we were aimed to investigate the changes of DC subsets after IR and its relationship with Th1/Th2 immunity. We found a significant decrease of BDCA3+DC in the blood of patients treated with radiotherapy. CD8+DC, a mouse equivalent of human BDCA3+DC, was also found decreased in mice spleen, peripheral blood and lymph node tissues after irradiation. As CD8+DC mainly induce Th1 immunity, we tested the changes of Th1/Th2 response and found that IR caused a repression of Th1 immunity, indicating a possible role of CD8+DC in radiation-induced Th1/Th2 imbalance. We also found that a CD8+DC-inducing cytokine, Fms-like tyrosine kinase 3 ligand (FLT3 ligand), restored CD8+DC and reversed Th1/Th2 shift. And then we found that bone marrow cells from irradiated mice differentiated into less CD8+DC, which was also protected by FLT3 ligand. In conclusion, our data showed that IR induced a decrease of CD8+DC and Th1/Th2 shift, which was reversed by Flt3 ligand treatment, suggesting a novel mechanism for radiation-induced immunosuppression.
Subject(s)
Dendritic Cells/radiation effects , Membrane Proteins/metabolism , Neoplasms/radiotherapy , Th1 Cells/radiation effects , Th2 Cells/radiation effects , Animals , Antigens, Surface/metabolism , CD8 Antigens/metabolism , Cell Differentiation , Cells, Cultured , Cytokines/metabolism , Dendritic Cells/immunology , Female , Humans , Immunosuppression Therapy , Mice , Mice, Inbred C57BL , Radiation, Ionizing , Th1 Cells/immunology , Th1-Th2 Balance/radiation effects , Th2 Cells/immunology , ThrombomodulinABSTRACT
BACKGROUND: We studied the mechanism by which fermented milk ameliorates UV-B-induced skin damage and determined the active components in milk fermented with lactic acid bacteria by evaluating erythema formation, dryness, epidermal proliferation, DNA damage and cytokine mRNA levels in hairless mice exposed to acute UV-B irradiation. METHODS: Nine week-old hairless mice were given fermented milk (1.3 g/kg BW/day) or exopolysaccharide (EPS) concentrate (70 mg/kg BW/day) orally for ten days. Seven days after fermented milk or EPS administration began, the dorsal skin of the mice was exposed to a single dose of UV-B (20 mJ/cm²). RESULTS: Ingestion of either fermented milk or EPS significantly attenuated UV-B-induced erythema formation, dryness and epidermal proliferation in mouse skin. Both fermented milk and EPS were associated with a significant decrease in cyclobutane pyrimidine dimers and upregulated mRNA levels of xeroderma pigmentosum complementation group A (XPA), which is involved in DNA repair. Furthermore, administration of either fermented milk or EPS significantly suppressed increases in the ratio of interleukin (IL)-10/IL-12a and IL-10/interferon-gamma mRNA levels. CONCLUSION: Together, these results indicate that EPS isolated from milk fermented with lactic acid bacteria enhanced DNA repair mechanisms and modulated skin immunity to protect skin against UV damage.
Subject(s)
Fermentation/drug effects , Lactic Acid/metabolism , Polysaccharides/isolation & purification , Polysaccharides/pharmacology , Skin/pathology , Skin/radiation effects , Ultraviolet Rays , Animals , Cell Proliferation/drug effects , Cytokines/metabolism , DNA Damage , Erythema/pathology , Female , Mice, Hairless , Milk , Models, Biological , RNA, Messenger/genetics , RNA, Messenger/metabolism , Skin/drug effects , Th1 Cells/drug effects , Th1 Cells/radiation effects , Th2 Cells/drug effects , Th2 Cells/radiation effects , Xeroderma Pigmentosum Group A Protein/genetics , Xeroderma Pigmentosum Group A Protein/metabolismABSTRACT
Immune status was studied in the framework of the current work and the results of the analysis of concentration of 26 characteristic parameters of innate and acquired immunity in 140 individuals from 56 trios (fathers, mothers and their Ist generation offspring that were included in 2 groups) are presented. Fathers and mothers of the children under study in the main groip Were exposed due to a long-term residence (from childhood to maturity) in the areas of Chelyabinsk region contaminated as a result of the-accident at Mayak PA (contamination included long-lived isotopes - 9°Sr and, to a smaller extent, ¹³7Cs and ²³9Pu) and then migrated into Ozyorsk prior to the conception of their children (75 individuals, 33 family trios). Comparison group (control) included parents and their offspring who are Ozyorsk residents never residing in the areas contaminated by radionuclides (65 individuals, 23 family trios). All the investigated individuals from the compared groups were of the corresponding age and gender and had never worked at nuclear facilities. Blood samples were obtained in the periods that excluded oncological, acute infectious and inflammatory diseases of any acute stages of chronic processes. Concentration of immune cells was measured by flow cytometer (Beckman Coulter, USA) using special monoclonal antibodies of the same manufacturer in a licensed medical center "Familia" (Chelyabinsk). The objective of the work is to assess the immune status in parents who migrated from contaminated areas prior to the conception of children and in their 1st generation offspring not exposed to radiation. Alterations of the immune status in the form of increase or, to a smaller extent, decrease of concentration of lymphocytes with effector and/or regulatory functions (B-1, T-helpers, NK, T-NK, late precursors of T-1 and T-1 of late activation) in blood of exposed parents and their offspring were detected in comparison with the results in the control group; that could possibly be related to the stimulation effect of low doses that support activation, proliferation and development of compensatory imbalance in the immune system and immunodeficiency in parents of the main group and in their offspring. In order to reveal the mechanisms of the detected alterations the interrelation between immune damage and incidence, of diseases among the cohorts involved in the current work will be studied further.
Subject(s)
Immune System/radiation effects , Lymphocytes/immunology , Occupational Exposure/adverse effects , Radioactive Hazard Release , Adolescent , Adult , Aged , B-Lymphocytes/immunology , B-Lymphocytes/pathology , B-Lymphocytes/radiation effects , Cesium Radioisotopes/adverse effects , Child , Child, Preschool , Female , Humans , Killer Cells, Natural/immunology , Killer Cells, Natural/pathology , Killer Cells, Natural/radiation effects , Lymphocytes/radiation effects , Male , Middle Aged , Pedigree , Plutonium/adverse effects , Radiation Dosage , Retrospective Studies , Strontium Radioisotopes/adverse effects , Th1 Cells/pathology , Th1 Cells/radiation effects , Young AdultABSTRACT
Two major CD4+ T-helper (Th) lineages are Th1 and Th2, and well balanced Th1/Th2 responses are essential for immune function. In previously published studies, it was reported that radiation induces a Th1/Th2 immune imbalance toward a Th2-dominant direction, and this imbalance may contribute to postirradiation immune dysfunction. The polarization of Th cells is driven by the cytokine milieu and controlled by intracellular regulatory pathways that respond to cytokine signaling. It is widely accepted that radiation induces cytokine aberration, however, the precise alterations of cytokines in various tissue environments have been difficult to evaluate. In addition, the effects of radiation on the intrinsic functions of Th cells remain uncharacterized. Therefore, how radiation affects Th1/Th2 balance remains somewhat unclear. To address this, we investigated the changes in the polarization capability of Th cells by isolating them from mice previously exposed to radiation and assessing the cells in an established in vitro Th polarization system. Our novel results demonstrate that prior exposure to radiation led to the persistent aberration of the inherent capability of Th cells to differentiate into Th1 and Th2 lineages. The parallel changes in expression of Th1-specific master transcription factors and the key genes in metabolic reprograming indicated that radiation affects the core components in Th1 polarization. While Th1 differentiation was impaired after irradiation, little adverse effect was observed in Th2 differentiation; both of these findings contribute to the known phenotypes of Th1/Th2 imbalance caused by radiation.
Subject(s)
Th1 Cells/cytology , Th1 Cells/radiation effects , Th2 Cells/cytology , Th2 Cells/radiation effects , Animals , CD4-Positive T-Lymphocytes/cytology , CD4-Positive T-Lymphocytes/radiation effects , Cytokines/metabolism , Down-Regulation/radiation effects , Male , Mice , T-Box Domain Proteins/metabolism , Th1 Cells/metabolism , Th2 Cells/metabolismABSTRACT
BACKGROUND: Exposure to ionizing radiation (IR) often causes severe damage to radiosensitive tissues, which limits the use of radiotherapy in cancer patients. Novel safe and effective radioprotectant is urgently required. It has been reported toll like receptor 2 (TLR2) plays a critical role in radioresistance. In this study, we demonstrated the protective effects of Heat-Killed Mycobacterium tuberculosis (HKMT), a potent TLR2 agonist, against IR. METHODS: Cell survival and apoptosis were determined by CCK-8 assay and Annexin V assay, respectively. An immunofluorescence staining assay was used to detect the translocation of nuclear faktor-kappa beta (NF-kB) p65. Tissue damage was evaluated by Haematoxilin-Eosin (HE) staining assay. We also used a flow cytometry assay to measure the number of nucleated cells and CD34+ hemopoietic stem cells in bone marrow. A western blot assay was used to detect the changes of proteins involving TLR signaling pathway. RESULTS: We found that HKMT increased cell viability and inhibited cell apoptosis after irradiation. HKMT induced NF-kB translocation and activated Erk1/2, p38 signaling pathway. HKMT also protected bone marrow and testis from destruction. Radiation-induced decreases of nucleated cells and CD34+ hemopoietic stem cells in bone marrow were also inhibited by HKMT treatment. We found that radiation caused increase of inflammatory cytokines was also suppressed by HKMT. CONCLUSION: Our data showed that HKMT exhibited radioprotective effects in vivo and in vitro through activating NF-kB and MAPK signaling pathway, suggesting a potential of HKMT as novel radioprotector.
Subject(s)
Hot Temperature , Mycobacterium tuberculosis/physiology , Radiation Tolerance/drug effects , Radiation-Protective Agents/pharmacology , Animals , Antigens, CD34/metabolism , Apoptosis/drug effects , Apoptosis/radiation effects , Cell Count , Cell Survival/drug effects , Cell Survival/radiation effects , Cells, Cultured , Cytokines/metabolism , Hematopoietic Stem Cells/drug effects , Hematopoietic Stem Cells/metabolism , Inflammation/pathology , MAP Kinase Signaling System/drug effects , MAP Kinase Signaling System/radiation effects , Male , Mice, Inbred BALB C , NF-kappa B/metabolism , Protein Transport/drug effects , Protein Transport/radiation effects , Radiation Injuries/pathology , Radiation Tolerance/radiation effects , Radiation, Ionizing , Testis/drug effects , Testis/pathology , Testis/radiation effects , Th1 Cells/drug effects , Th1 Cells/immunology , Th1 Cells/radiation effects , Th2 Cells/drug effects , Th2 Cells/immunology , Th2 Cells/radiation effectsABSTRACT
Bovine α-lactalbumin (ALA) is a known food allergen present in milk to induce anaphylaxis. A previous study demonstrated that irradiated ALA (iALA) decreased the IgE-binding properties and weakened the degranulation capacity of basophils in vitro. The present study aimed to further assess the potential allergenicity of iALA in vivo in a BALB/c mouse model. The mice (n = 10/group) were intragastrically sensitized and orally challenged with either iALA or ALA using cholera toxin as adjuvant. In contrast to the ALA group, the iALA group did not show anaphylactic shock symptoms. A tendency toward decreased serum allergen-specific IgG/IgG1/IgE levels, plasma histamine levels and mast cell protease-1 (mMCP-1) concentrations in the iALA group were also observed, accompanied by a decrease in Th2-related cytokine levels and an increase of IFN-γ production in spleen cell cultures. Moreover, the peritoneal mast cell surface expression of FcεRI and peripheral blood basophil CD200R+ expression were decreased by 64.3% and 35.19%, respectively. Conversely, the percentage of CD4+CD25+Foxp3+ regulatory T cells increased in the iALA group. All of these findings indicated that iALA induces a shift toward the Th1 response, which ultimately reduces its potential allergenicity.
Subject(s)
Allergens/pharmacology , Food Hypersensitivity/immunology , Lactalbumin/pharmacology , T-Lymphocytes, Regulatory/immunology , Th1 Cells/immunology , Allergens/administration & dosage , Animals , Basophils/metabolism , Cattle , Cytokines/blood , Female , Gamma Rays , Histamine/blood , Immunoglobulins/blood , Lactalbumin/administration & dosage , Mast Cells/immunology , Mast Cells/metabolism , Mast Cells/radiation effects , Mice , Mice, Inbred BALB C , T-Lymphocytes, Regulatory/radiation effects , Th1 Cells/radiation effectsABSTRACT
PURPOSE: Inefficient T-cell reconstitution from x-ray-induced immune damage reduces antitumor response. To understand the profile of T-cell reconstitution after irradiation will overcome the barrier of antitumor immunity. This study aimed to identify the recovery profile of T-cell subsets following x-ray irradiation and to highlight the role of cinnamon on efficient T-cell restoration postexposure in the antitumor response. METHODS AND MATERIALS: CD3(+), CD8(+), and CD4(+) T cells and Th1, Th2, Th17, and regulatory T (Treg) cells were evaluated at different time points after single low-dose total body irradiation (SLTBI) with or without cinnamon treatments. T-bet, GATA3, RORγt, and Foxp3 signaling specific for Th1, Th2, Th17, and Treg were also analyzed by RT-PCR assay. The effects of cinnamon on efficient T-cell subset reconstitution was confirmed in a lung melanoma model in irradiated mice. RESULTS: Reconstitution of CD4(+) T cells was delayed more than that of CD8(+) T cells in T-cell restoration after SLTBI. The production of IFNγ by Th1 or Tc1 cells was sharply decreased and was accompanied by reduced T-bet mRNA, even when total T-cell numbers had recovered; the frequencies of Th17 and Treg cells and their specific transcription factors (RORγt and Foxp3, respectively) were obviously increased. Irradiation-induced inefficient T-cell reconstitution impaired the antitumor capacities in the lung melanoma model. Pretreatment with cinnamon in irradiated mice accelerated the generation of Th1 and reduced the differentiation of Treg cells by activating T-bet and limiting transcriptions of Foxp3. Improvement resulting from cinnamon pretreatment on the efficient T-cell recovery profile from SLTBI promoted antitumor immunity in the lung melanoma model. CONCLUSIONS: T-cell reconstitution from SLTBI was characterized by impaired Th1 and elevated Th17 and Treg cells. Cinnamon effectively improved the imbalance of T-cell subsets by promoting the proliferation of Th1 and by suppressing expansions of Th17 and Tregs. The role of cinnamon in efficient T-cell reconstitution from SLTBI is effective in antitumor immunity.
Subject(s)
Plant Extracts/pharmacology , T-Lymphocyte Subsets/drug effects , T-Lymphocyte Subsets/radiation effects , Whole-Body Irradiation/adverse effects , Analysis of Variance , Animals , CD4-Positive T-Lymphocytes/cytology , CD4-Positive T-Lymphocytes/drug effects , CD4-Positive T-Lymphocytes/metabolism , CD4-Positive T-Lymphocytes/radiation effects , CD8-Positive T-Lymphocytes/cytology , CD8-Positive T-Lymphocytes/drug effects , CD8-Positive T-Lymphocytes/metabolism , CD8-Positive T-Lymphocytes/radiation effects , Cinnamomum zeylanicum , Female , Flow Cytometry , Forkhead Transcription Factors/metabolism , GATA3 Transcription Factor/metabolism , Immunity, Cellular/radiation effects , Interferon-gamma/metabolism , Intracellular Signaling Peptides and Proteins/metabolism , Melanoma, Experimental/immunology , Melanoma, Experimental/pathology , Melanoma, Experimental/prevention & control , Mice , Mice, Inbred C57BL , Nuclear Receptor Subfamily 1, Group F, Member 3/metabolism , RNA Polymerase I , RNA, Messenger/metabolism , Radiotherapy Dosage , Reverse Transcriptase Polymerase Chain Reaction , T-Box Domain Proteins/metabolism , T-Lymphocyte Subsets/cytology , T-Lymphocyte Subsets/metabolism , T-Lymphocytes, Regulatory/cytology , T-Lymphocytes, Regulatory/drug effects , T-Lymphocytes, Regulatory/metabolism , T-Lymphocytes, Regulatory/radiation effects , Th1 Cells/cytology , Th1 Cells/drug effects , Th1 Cells/metabolism , Th1 Cells/radiation effects , Th17 Cells/cytology , Th17 Cells/drug effects , Th17 Cells/metabolism , Th17 Cells/radiation effectsABSTRACT
Nanoparticles in the field of dendritic cell (DC) research are emerging as a promising method of enhancing the efficacy of cancer immunotherapy. We investigated the effect of branched polyethylenimine-superparamagnetic iron oxide nanoparticles (bPEI-SPIONs) on tumor cells loaded onto DCs. The tumor antigens were prepared as follows: (1) apoptotic U266 cells with ultraviolet B (UVB) irradiation followed by a 2 h incubation in the absence (2 h postirradiated cells) or (2) presence of bPEI-SPIONs (bPEI-SPION 2 h postirradiated cells) and (3) apoptotic U266 cells with UVB irradiation followed by an overnight 16 h incubation (16 h postirradiated cells). bPEI-SPIONs render U266 cells sensitive to UVB irradiation through reactive oxygen species production to accelerate apoptotic death. The 2 h postirradiated cells and bPEI-SPION 2 h postirradiated cells released immunogenic proteins, including Hsp70, Hsp90, and HMGB1. The DCs loaded with bPEI-SPION 2 h postirradiated cells showed the highest IL-12p70 production and Th1 polarization compared with other DCs. These results suggest that bPEI-SPIONs are a promising method of enhancing the immunogenicity of tumor cells and promoting Th1 polarization of DCs loaded with these tumor cells.
Subject(s)
Antigens, Neoplasm/immunology , Dendritic Cells/immunology , Magnetite Nanoparticles/chemistry , Polyethyleneimine/chemistry , Th1 Cells/immunology , Antigens, Neoplasm/chemistry , Antigens, Surface/metabolism , Apoptosis/drug effects , Apoptosis/radiation effects , Cell Line , Cell Membrane/metabolism , Cell Movement , Dendritic Cells/drug effects , Dendritic Cells/metabolism , Heat-Shock Proteins/metabolism , Humans , Polyethyleneimine/administration & dosage , Reactive Oxygen Species/metabolism , Signal Transduction/drug effects , Signal Transduction/radiation effects , Th1 Cells/metabolism , Th1 Cells/radiation effects , Ultraviolet RaysABSTRACT
We have previously found that an imbalance of Tc1/Tc2 T cell subtypes in vivo impacts the development of photodermatitis. The aim of this study was to investigate the relationship between cytokines derived from keratinocytes exposure to UV and the imbalance of Th subgroups. We used different doses of UVA and UVB to irradiate HaCaT cells. Twelve hours after irradiation, the expression of IL-10R, IL-4R, IL-12R, and IFN-γR proteins was observed using the S-P method, and the percentage of positive cells calculated. Protein levels of the respective ligands in the supernatant was measured by ELISA. Our results showed low levels of expression of the interrogated proteins in unirradiated HaCaT cells, and little or no expression could be detected in the supernatant. Little or no expression was also observed for IL-12R and IFN-γR 12 h after UVA or UVB irradiation. However, the expression of IL-10R and IL-10 was upregulated 12 h following UVB irradiation, as well as following lower dose UVA irradiation. In contrast, higher dose UVA decreased the expression of IL-10R and IL-10. The expression of IL-4R was increased following high doses of UVA and UVB irradiation, whereas no expression was observed after lower dose UV exposure. There was no change in IL-4 secretion into the supernatant. Our results demonstrate that the effects of UV exposure on keratinocyte-derived cytokines are different according to the doses of irradiation and the types of cytokines, and suggest that keratinocyte-derived cytokines after UV exposure might cause an imbalance of Th1/Th2.
Subject(s)
Cytokines/metabolism , Keratinocytes/metabolism , Keratinocytes/radiation effects , Th1 Cells/cytology , Th2 Cells/cytology , Ultraviolet Rays , Cell Line , Cell Shape/radiation effects , Enzyme-Linked Immunosorbent Assay , Humans , Immunohistochemistry , Receptors, Interferon/metabolism , Receptors, Interleukin/metabolism , Th1 Cells/radiation effects , Th2 Cells/radiation effects , Interferon gamma ReceptorABSTRACT
Regulatory T cells (Tregs) is one of the main obstacles to the success of cancer immunotherapy. The effect of dendritic cell (DC)-based immunotherapy can be attenuated by immune suppressive functions of Tregs. We used a CD25-targeted antibody and low-dose cyclophosphamide (CTX) as immunomodulators to increase the antitumor effect of intratumoral injection of immature DCs into the irradiated tumor cells (IR/iDC). CTX or CD25-targeted antibody alone showed a significant reduction in the number of Tregs within the tumor microenvironment. When they are combined with IR/iDC, the number of Tregs was further reduced. Although IR/IDC showed strong antitumor effects such as reduction in tumor growth, increase in Th1 immune response, and improvement of survival, the therapeutic effect was further improved by combining treatments with immunomodulators. CTX and CD25-targeted antibody showed no significant difference in tumor growth when combined with IR/iDC, but CTX further increased the number of interferon (IFN)-γ-secreting T cells, cytotoxicity, and survival rate. Although irradiation induced depletion of T lymphocytes, administration of DCs recovered this depletion. Particularly, the lymphocytes were more significantly increased when CTX and IR/iDC were combined. Low-dose CTX has already been used as an immunomodulator in clinical trials, and it offers several advantages, including convenience, low-cost, and familiarity to clinicians. However, CD25-targeted antibody cannot only deplete Tregs, but also may affect IL-2-dependent effector T lymphocytes. Therefore, CTX is an effective means to inhibit Tregs, and an effective immunomodulatory agent for multimodality therapy such as combination treatment of conventional cancer therapy and immunotherapy.
Subject(s)
Antibodies, Monoclonal/administration & dosage , Antineoplastic Agents/administration & dosage , Carcinoma, Lewis Lung/immunology , Cyclophosphamide/administration & dosage , Dendritic Cells/immunology , Interleukin-2 Receptor alpha Subunit/antagonists & inhibitors , Animals , Apoptosis/drug effects , Apoptosis/radiation effects , Carcinoma, Lewis Lung/mortality , Carcinoma, Lewis Lung/pathology , Carcinoma, Lewis Lung/therapy , Cell Line, Tumor , Combined Modality Therapy , Cytotoxicity, Immunologic/drug effects , Cytotoxicity, Immunologic/radiation effects , Disease Models, Animal , Dose-Response Relationship, Drug , Dose-Response Relationship, Radiation , Immunophenotyping , Immunosuppressive Agents/administration & dosage , Immunotherapy , Male , Mice , Phenotype , Radiation , Spleen/immunology , T-Lymphocytes, Regulatory/drug effects , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/metabolism , T-Lymphocytes, Regulatory/radiation effects , Th1 Cells/drug effects , Th1 Cells/immunology , Th1 Cells/metabolism , Th1 Cells/radiation effects , Tumor Microenvironment/drug effects , Tumor Microenvironment/immunology , Tumor Microenvironment/radiation effectsABSTRACT
BACKGROUND: To investigate the effects of double radiofrequency hyperthermia on Th1/Th2 cells in esophageal cancer patients treated with radiotherapy. MATERIALS AND METHODS: 22 patients with esophageal cancer were divided into a radiotherapy group (10 cases) and a combined group (double radiofrequency hyperthermia combined with radiotherapy group, 12 cases). Both groups received conventional radiotherapy using a cobalt-60 therapy apparatus (TD60-66Gy/30-33F). Patients in the combined group also underwent double radiofrequency hyperthermia (2F/W, 8-10F). Before and after treatment, Th1, Th2, Tc1 and Tc2 cells in peripheral blood were determined with flow cytometry. RESULTS: In the radiotherapy group, Th1 cell contents before and after radiotherapy were 17.5 ± 5.26% and 9.69 ± 4.86%, respectively, with a significant difference (p<0.01). The Th1/Th2 ratio was significantly decreased from 28.2 ± 14.3 to 16.5 ± 10.4 (p<0.01). In the combined group, Th1 cell content before radiotherapy was 15.9 ± 8.18%, and it increased to 18.6 ± 8.84 after radiotherapy (p>0.05), the Th1/Th2 ratio decreasing from 38.4 ± 36.3 to 28.1 ± 24.0 (p>0.05). Changes in Th2, Tc1 and Tc2 cell levels were not significant in the two groups before and after therapy (p>0.05). CONCLUSIONS: Double radiofrequency hyperthermia can promote the conversion from Th2 to Th1 cells, and regulate the balance of Th1/Th2 cells.
Subject(s)
Esophageal Neoplasms/radiotherapy , Th1 Cells/radiation effects , Th2 Cells/radiation effects , Aged , Female , Humans , Hyperthermia, Induced/methods , Male , Middle AgedABSTRACT
Chemokines may contribute to the systemic inflammation that is linked to the increased risk of co-morbidities in patients with psoriasis. The aim of this study was to investigate circulating chemokines in patients with psoriasis and their relationship to disease severity. Analysis of plasma levels of chemokines in patients with psoriasis before narrowband ultraviolet B (UVB) therapy revealed increased expression of Th1-associated CXCL9 and -10, Th2-associated CCL17 and CCL22, and Th17-associated CCL20. CCL20 correlated with disease severity. UVB therapy reduced skin symptoms, but did not affect the chemokine levels in plasma. Anti-CD3 and anti-CD28-mediated activation of peripheral blood mononuclear cells (PBMCs) caused a higher secretion of Th2 cytokine interleukin (IL)-13 by PBMCs from patients with psoriasis than from healthy controls. The sustained high expression of inflammatory chemokines is a potential link to systemic inflammation in psoriasis. UVB therapy may be a more effective treatment of local rather than systemic inflammation.
Subject(s)
Chemokines/blood , Inflammation Mediators/blood , Psoriasis/radiotherapy , Th1 Cells/radiation effects , Th17 Cells/radiation effects , Th2 Cells/radiation effects , Ultraviolet Therapy , Adult , Aged , Biomarkers/blood , Case-Control Studies , Cells, Cultured , Female , Humans , Male , Middle Aged , Psoriasis/blood , Psoriasis/epidemiology , Severity of Illness Index , Th1 Cells/immunology , Th17 Cells/immunology , Th2 Cells/immunology , Time Factors , Treatment Outcome , Up-Regulation , Young AdultABSTRACT
Whole body irradiated mice appear to experience a down-regulation of the helper T (Th)1-like immune response, and maintain a persistent immunological imbalance. In the current study, we evaluated the effect of HemoHIM (an herbal product made from Angelica Radix, Cnidium officinale , and Paeonia japonica cultivated in Korea) to ameliorate the immunological imbalance induce in fractionated γ-irradiated mice. The mice were exposed to γ rays twice a week (0.5 Gy fractions) for a total dose of 5 Gy, and HemoHIM was administrated orally from 1 week before the first irradiation to 1 week before the final analysis. All experiments were performed 4 and 6 months after their first exposure. HemoHIM ameliorated the Th1- and Th2-related immune responses normally occur in irradiated mice with or without dinitrophenylated keyhole limpet hemocyanin immunization. HemoHIM also restored the natural killer cell activities without changing the percentage of natural killer cells in irradiated mice. Furthermore, the administration of HemoHIM prevented the reduction in levels of interleukin-12p70 in irradiated mice. Finally, we found that HemoHIM enhanced the phosphorylation of signal transducer and activator of transcription (STAT) 4 that was reduced in irradiated mice. Our findings suggest that HemoHIM ameliorates the persistent down-regulation of Th1-like immune responses by modulating the IL-12p70/pSTAT4 signaling pathway.
Subject(s)
Gamma Rays/adverse effects , Immunologic Deficiency Syndromes/prevention & control , Interleukin-12/physiology , Killer Cells, Natural/drug effects , Phytotherapy , Plant Extracts/therapeutic use , Radiation Injuries, Experimental/drug therapy , Radiation-Protective Agents/therapeutic use , STAT4 Transcription Factor/physiology , Signal Transduction/drug effects , Th1 Cells/drug effects , Whole-Body Irradiation/adverse effects , Animals , Antibody Formation/drug effects , Antibody Formation/radiation effects , Cytotoxicity, Immunologic/drug effects , Cytotoxicity, Immunologic/radiation effects , Dose Fractionation, Radiation , Down-Regulation/drug effects , Drug Evaluation, Preclinical , Female , Immunization , Immunologic Deficiency Syndromes/etiology , Killer Cells, Natural/immunology , Killer Cells, Natural/radiation effects , Lymphokines/metabolism , Mice , Mice, Inbred C57BL , Phosphorylation/drug effects , Plant Extracts/pharmacology , Protein Processing, Post-Translational/drug effects , Radiation Injuries, Experimental/immunology , Radiation-Protective Agents/pharmacology , Specific Pathogen-Free Organisms , Spleen/immunology , Spleen/pathology , Spleen/radiation effects , Th1 Cells/metabolism , Th1 Cells/radiation effects , Th2 Cells/drug effects , Th2 Cells/metabolism , Th2 Cells/radiation effectsABSTRACT
PURPOSE: Changes in the Th1/Th2 immune balance may play a role in increasing the incidence of radiation-induced toxicity. This study evaluates the consequences of Th1 deficiency on intestinal response (fibrosis and T cell trafficking) to abdominal irradiation and examines in mucosa and mesenteric lymph nodes (MLN) the differential involvement of the two Th1 pathways, T-bet/STAT1 and IL-12/STAT4, in controlling this balance in mice. METHODS AND MATERIALS: Using T-bet-deficient mice (T-bet-/-), we evaluated the mRNA and protein expression of the Th1 pathways (IFN-γ, T-bet/STAT1, and IL-12/STAT4) and the CD4+ and CD8+ populations in ileal mucosa and MLN during the first 3 months after 10 Gy abdominal irradiation. RESULTS: The T-bet-deficient mice showed an increased fibrotic response to radiation, characterized by higher TGF-ß1, col3a1 expression, and collagen deposition in mucosa compared with wild-type mice. This response was associated with drastically lower expression of IFN-γ, the hallmark Th1 cytokine. Analysis of the Th1 expression pathways, T-bet/STAT1 and IL-12/STAT4, showed their equal involvement in the failure of Th1 polarization. A minimal IFN-γ level depended on the IL-23-p19/STAT4 level. In addition, the radiation-induced deficiency in the priming of Th1 by IFN-γ was related to the defective homing capacity of CD8+ cells in the mucosa. CONCLUSION: Irradiation induces Th2 polarization, and the Th2 immune response may play a role in potentiating irradiation-induced intestinal collagen deposition.
Subject(s)
Cell Movement/radiation effects , Ileum/radiation effects , Interferon-gamma/metabolism , Intestinal Mucosa/radiation effects , T-Box Domain Proteins/deficiency , Th1 Cells/cytology , Th2 Cells/cytology , Animals , CD4-CD8 Ratio , CD4-Positive T-Lymphocytes/cytology , CD4-Positive T-Lymphocytes/radiation effects , CD8-Positive T-Lymphocytes/cytology , CD8-Positive T-Lymphocytes/radiation effects , Cell Differentiation/physiology , Collagen Type III/metabolism , GATA3 Transcription Factor/metabolism , Ileum/immunology , Ileum/metabolism , Interleukin-12/physiology , Interleukin-12 Subunit p35/metabolism , Interleukin-12 Subunit p40/metabolism , Interleukin-23 Subunit p19/metabolism , Intestinal Mucosa/immunology , Intestinal Mucosa/metabolism , Lymph Nodes/cytology , Mice , Mice, Inbred C57BL , RNA, Messenger/metabolism , STAT1 Transcription Factor/genetics , STAT1 Transcription Factor/metabolism , STAT4 Transcription Factor/genetics , STAT4 Transcription Factor/metabolism , T-Box Domain Proteins/metabolism , Th1 Cells/metabolism , Th1 Cells/radiation effects , Th2 Cells/metabolism , Th2 Cells/radiation effects , Time Factors , Transforming Growth Factor beta1/genetics , Transforming Growth Factor beta1/metabolismABSTRACT
We previously showed that exposure to UV radiation after immunization suppresses Th1 and Th2 immune responses, leading to impaired Ab and allo-immune responses, but the impact of UV radiation after immunization on anti-tumor immune responses mediated by tumor-specific CD8(+) T cell responses remains less clear. Furthermore, the exact phenotypic and functional characteristics of regulatory T cell population responsible for the UV-induced immunosuppression still remain elusive. Using the MBL-2 lymphoma cell line engineered to express OVA as a surrogate tumor Ag, here we demonstrate that UV irradiation after tumor Ag-immunization suppresses the anti-tumor immune response in a manner dependent on the immunizing Ag. This suppression was mediated by interleukin (IL)-10 released from CD4(+) CD25(+) T cells, by which impaired the induction of cytotoxic T lymphocytes (CTL) able to kill Ag-expressing tumor cells. In addition, we generated a panel of T cell clones from UV-irradiated and non-irradiated mice, and all of the clones derived from UV-irradiated mice had a Tr1-type regulatory T cell phenotype with expression of IL-10 and c-Maf, but not Foxp3. These Tr1-type regulatory T cell clones suppressed tumor rejection in vivo as well as Th cell activation in vitro in an IL-10 dependent manner. Given that suppression of Ag-specific CTL responses can be induced in Ag-sensitized mice by UV irradiation, our results may imply that exposure to UV radiation during premalignant stage induces tumor-Ag specific Tr1 cells that mediate tumor-Ag specific immune suppression resulting in the promotion of tumor progression.